At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PDX PIMCO DYNAMIC INCOME STRATEGY FUND
Closed 08-24 16:00:00 EDT
21.64
-0.05
-0.23%
盘后21.51
-0.13-0.61%
19:30 EDT
High21.80Low21.62Vol79.99K
Open21.73D1 Closing21.69Amplitude0.83%
Mkt Cap967.46MTradable Cap967.46MTotal Shares44.71M
T/O1.74MT/O Rate0.18%Tradable Shares44.71M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Pimco Portfolio Manager Greg Elliot Sharenow Buys $131,030 of Pimco Dynamic Income Strategy Fund Common Shares
Reuters  ·  08-21
Pimco Portfolio Manager Greg Elliot Sharenow Buys $131,030 of Pimco Dynamic Income Strategy Fund Common Shares
Saba Capital Management Disposes of $291,530 Pimco Dynamic Income Strategy Fund Shares
Reuters  ·  08-19
Saba Capital Management Disposes of $291,530 Pimco Dynamic Income Strategy Fund Shares
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
GlobeNewswire  ·  08-12
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
PIMCO Executive Committee Member Thibault Christian Stracke Acquires PIMCO Dynamic Income Strategy Fund Common Shares Worth $540,468‬
Reuters  ·  08-11
PIMCO Executive Committee Member Thibault Christian Stracke Acquires PIMCO Dynamic Income Strategy Fund Common Shares Worth $540,468‬
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
GlobeNewswire  ·  08-06
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Dow Jones  ·  08-04
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Pimco Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale
Reuters  ·  07-09
Pimco Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale
Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions
Dow Jones  ·  07-02
Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions
Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones  ·  05-27
Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
PIMCO portfolio manager Greg Elliot Sharenow buys USD 385,769 Pimco Dynamic Income Strategy Fund shares
Reuters  ·  05-22
PIMCO portfolio manager Greg Elliot Sharenow buys USD 385,769 Pimco Dynamic Income Strategy Fund shares
Pimco portfolio manager Greg Elliot Sharenow buys PIMCO Dynamic Income Strategy Fund shares for $107,630
Reuters  ·  05-19
Pimco portfolio manager Greg Elliot Sharenow buys PIMCO Dynamic Income Strategy Fund shares for $107,630
Pimco Dynamic Income Strategy Fund announces shareholder meeting
Reuters  ·  05-14
Pimco Dynamic Income Strategy Fund announces shareholder meeting
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Dow Jones  ·  05-02
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
PIMCO portfolio manager Daniel J. Ivascyn buys $592,327 Pimco Dynamic Income Strategy Fund shares
Reuters  ·  04-30
PIMCO portfolio manager Daniel J. Ivascyn buys $592,327 Pimco Dynamic Income Strategy Fund shares
Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
GlobeNewswire  ·  04-23
Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models
Stock News  ·  04-23
TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
GlobeNewswire  ·  04-22
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform
GlobeNewswire  ·  04-22
Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
GlobeNewswire  ·  04-20
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
Saba Capital Management Disposes Pimco Dynamic Income Strategy Fund Common Shares
Reuters  ·  03-03
Saba Capital Management Disposes Pimco Dynamic Income Strategy Fund Common Shares

Introduction

Company Name.
PIMCO DYNAMIC INCOME STRATEGY FUND
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Issue price:
--